top of page
Detect early.
Live fully.
High-accuracy blood tests for ovarian cancer. Backed by science, built for labs, trusted by doctors, and made to give women answers sooner.
Our supporters
Our tests detect multiple biomarkers at once.
Most tumour markers ignore the sugars (glycans) on proteins. Ours don’t - that’s the difference. Our platform detects multiple glycoform biomarkers in a single test, improving diagnostic accuracy and reducing false alarms. No new equipment, just hard science that works.
What we’re building is already changing lives
Our biomarkers are licensed from leading medical institutes, validated through peer-reviewed research, and built to meet global regulatory standards.
8 million lives at risk by 2050 without early detection
4 years longer for women to receive diagnosis vs men, across many conditions
10x higher risk of ovarian cancer in women with endometriosis
No new reagents or equipment needed. Runs on clinical mass spectrometers
One platform from R&D to clinical test—no delays, no bottlenecks
Get the latest on our diagnostics
Receive clinical updates and diagnostic developments focused on early detection and women’s health.
bottom of page